TY - JOUR
T1 - Synthesis and binding affinities of fluoroalkylated raloxifenes
AU - Lee, Kyo Chul
AU - Moon, Byung Seok
AU - Lee, Jae Hak
AU - Chung, Kyoo Hyun
AU - Katzenellenbogen, John A.
AU - Chi, Dae Yoon
N1 - Funding Information:
This work was supported by Korea Research Foundation Grant (KRF-2000-015-DP0274). We thank Kathryn Carlson for the binding affinity determinations.
PY - 2003/8/15
Y1 - 2003/8/15
N2 - Three fluoroalkylated derivatives (1-3) of the selective estrogen receptor modulator (SERM), raloxifene, have been synthesized. The key step in the synthesis is the C-C bond formation of benzo[b]thiophene and a substituted phenyl group (ring C) using a Stille reaction. The in vitro binding affinities of the substituted raloxifenes 1-3 are 45, 60, 89%, respectively, relative to the affinity of estradiol, which is higher than the affinity of raloxifene itself (25%). When labeled with the positron-emitting radionuclide, these compounds might be useful as PET imaging agents for estrogen receptor-positive breast tumors.
AB - Three fluoroalkylated derivatives (1-3) of the selective estrogen receptor modulator (SERM), raloxifene, have been synthesized. The key step in the synthesis is the C-C bond formation of benzo[b]thiophene and a substituted phenyl group (ring C) using a Stille reaction. The in vitro binding affinities of the substituted raloxifenes 1-3 are 45, 60, 89%, respectively, relative to the affinity of estradiol, which is higher than the affinity of raloxifene itself (25%). When labeled with the positron-emitting radionuclide, these compounds might be useful as PET imaging agents for estrogen receptor-positive breast tumors.
UR - http://www.scopus.com/inward/record.url?scp=0041620649&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0041620649&partnerID=8YFLogxK
U2 - 10.1016/S0968-0896(03)00362-6
DO - 10.1016/S0968-0896(03)00362-6
M3 - Article
C2 - 12901910
AN - SCOPUS:0041620649
SN - 0968-0896
VL - 11
SP - 3649
EP - 3658
JO - Bioorganic and Medicinal Chemistry
JF - Bioorganic and Medicinal Chemistry
IS - 17
ER -